Limiting medical appointments when it's reasonable to do so has helped columnist Anna Jeter manage her chronic care load.

Reading Lena Dunham's memoir "Famesick" reminds columnist Mike Naple that a chronic illness is not something that's just ...

The FDA has granted orphan drug designation to IKT-001, an experimental formulation of imatinib being developed to treat PAH.

Researchers have identified shared molecular connections between COVID-19 and PAH that may explain common disease features, a ...

People with PAH have less diversity among the viruses that infect bacteria in the digestive tract, according to a study.

A large clinical trial testing a once-daily inhaled treatment for PAH is now recruiting, after data showed long-term benefits ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Phaware Global Association ® is a 501(c)3 organization dedicated to raising global pulmonary hypertension awareness and creating innovative technology for PH research. Phaware® was co-founded by ...

People with pulmonary arterial hypertension (PAH) who were treated with the inhaled therapy seralutinib in a clinical trial tended to have better improvements in exercise capacity than those given a ...

Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears to be working as intended, according to newly ...

Pulmonary hypertension (PH) is a rare but severe condition characterized by high blood pressure that affects pulmonary arteries – the vessels responsible for transporting blood from the heart to the ...